Oleic Acid

Oleic Acid

SCHEMBL3960296

CCCCCCCCC=CCCCCCCCC(=O)O.O=c1ccc2ccccc2o1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.57
PPARG P37231 5/20 0.55
PPARD Q03181 5/20 0.55
PPARA Q07869 5/20 0.55
F7 P08709 4/20 0.55
F3 P13726 4/20 0.55
TERT O14746 3/20 0.55
PTPN1 P18031 3/20 0.55
HSD17B10 Q99714 3/20 0.55
FABP4 P15090 3/20 0.55
FAAH O00519 3/20 0.55
MAPT P10636 2/20 0.55
BLM P54132 2/20 0.55
LMNA P02545 2/20 0.55
ALOX15 P16050 2/20 0.55
DUSP3 P51452 2/20 0.55
CYP19A1 P11511 2/20 0.55
PTGS1 P23219 2/20 0.55
NR4A2 P43354 2/20 0.55
SIRT6 Q8N6T7 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oleic Acid SCHEMBL3960293 1.00 EPHX2 (0.57) EPHX2PPARGPPARDPPARAF7
Arachidonic Acid SCHEMBL1128241 0.94 PPARG (0.58) EPHX2PPARGPPARDPPARAF7
Arachidonic Acid SCHEMBL1128240 0.94 PPARG (0.58) EPHX2PPARGPPARDPPARAF7
Myristic Acid SCHEMBL28706218 0.93 TDP1 (0.56) EPHX2PPARGPPARDPPARAPTPN1
Palmitic Acid SCHEMBL28715453 0.93 TDP1 (0.56) EPHX2PPARGPPARDPPARAPTPN1
Stearic Acid SCHEMBL4535448 0.93 TDP1 (0.56) EPHX2PPARGPPARDPPARAPTPN1
Coumarin SCHEMBL28038376 0.82 CA12 (0.59) FAAHLMNATDP1ALDH1A1KDM4E
Arachidonic Acid SCHEMBL28529406 0.81 ALDH1A1 (0.56) EPHX2PPARGPPARDPPARAF7
Coumarin SCHEMBL29133124 0.80 CA12 (0.56) MAPTBLMLMNAALOX15TDP1
Oleic Acid SCHEMBL28102816 0.79 PPARG (0.68) PPARGPPARDPPARAF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1924671-A4 FLUORESCENT MARKER COMPRISING DOUBLE BOND ESTER GROUP AND METHOD FOR MARKING AND DETECTING THE SAME SIM HYUN-HO (KR) 2009-07-15 EP disclosed
US-20090104711-A1 FLUORESCENT MARKER COMPRISING DOUBLE BOND ESTER GROUP AND METHOD FOR MARKING AND DETECTING THE SAME SIM HYUN-HO 2009-04-23 US disclosed
EP-1924671-A1 FLUORESCENT MARKER COMPRISING DOUBLE BOND ESTER GROUP AND METHOD FOR MARKING AND DETECTING THE SAME Sim, Hyun-Ho (KR) 2008-05-28 EP disclosed
WO-2007037586-A1 FLUORESCENT MARKER COMPRISING DOUBLE BOND ESTER GROUP AND METHOD FOR MARKING AND DETECTING THE SAME SIM HYUN-HO (KR) 2007-04-05 WO disclosed
US-20030073109-A1 Methods for preparing improved enzyme variants KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090104711-A1 FLUORESCENT MARKER COMPRISING DOUBLE BOND ESTER GROUP AND METHOD FOR MARKING AND DETECTING THE SAME ELOVL1, FASN, ELOVL5 EPHX2 84/4885PPARG 61/4885PPARD 258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.